Physician profile
Thomas Lu
NPI 1669469730
$1,549.34
in general payments reported to CMS, 2019-2025
9 companies · $56.10 in 2025
The $56.10 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $16.86 · 2022: $165 · 2023: $636 · 2024: $431 · 2025: $56.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $441.72 | 2019-2024 | Spaceoar Vue System - 10ml |
| Ge Healthcare | $346.08 | 2023 | |
| Angiodynamics, INC. | $319.58 | 2023-2025 | Nanoknife, Biosentry Tract Sealant System, Solero |
| Penumbra, INC. | $153.84 | 2024 | Indigo System |
| Delcath Systems | $139.99 | 2024 | Hepzato Kit |
| Bard Peripheral Vascular, INC. | $83.00 | 2019 | |
| Medtronic USA, INC. | $30.00 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $18.27 | 2019 | |
| Cook Medical LLC | $16.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.